Challenges and Opportunities for Drug Repositioning in Fibrodysplasia Ossificans Progressiva

Fibrodysplasia ossificans progressiva (FOP) is an ultrarare congenital disease that progresses through intermittent episodes of bone formation at ectopic sites. FOP patients carry heterozygous gene point mutations in activin A receptor type I ACVR1, encoding the bone morphogenetic protein (BMP) type...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Biomedicines
Huvudupphovsmän: Ventura, Francesc, Williams, Eleanor, Ikeya, Makoto, Bullock, Alex N., ten Dijke, Peter, Goumans, Marie-José, Sanchez-Duffhues, Gonzalo
Materialtyp: Artigo
Språk:Inglês
Publicerad: MDPI 2021
Ämnen:
Review
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC7922784/
https://ncbi.nlm.nih.gov/pubmed/33669809
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/biomedicines9020213
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk